Delivery Order SPE2DB20D2104-SPE2DB25FMHXM
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, ID SPE2DB22D2006|SPE2DB25FV6CW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $65,485.32 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with the ID SPE2DB20D1110|SPE2DB24FK45F, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, with a ceiling value of $10,987.22 and a performance period through August 15, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts and Indefinite...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FALS3, is a Delivery Order valued at $26,441.64 that was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a medical product, with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $14,881.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of November 25, 2024, and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $11,314.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) and has a Firm Fixed Price pricing type. The contract is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date...
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB24FF3FD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $21,715.47 firm fixed-price delivery order is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, with a period of performance ending on February 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FQXE1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,901.82 firm-fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a broader...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FG4Q9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,495.90 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription drug. The contract has an ultimate completion date of July 17, 2024 and was awarded on July 16, 2024. It is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNY74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with an ultimate completion date of December 31, 2024 and a ceiling value of $2,543.11. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award with ID SPE2DB20D1047|SPE2DB23FF85L was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,376.18 firm fixed price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a completion date of September 26, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...